Higher cost for medicines under TPP trade agreement

Play
Stop
 
 

Cost of medicines could sky-rocket under a new multi-nation trade agreement. The twelve nations involved in the TPP are meeting in Hawaii to finalise details of the proposed agreement, some five years on. But some are left concerned any deal on pharmaceutical trade could mean rise in costs and more pressure on those who need the medicines most.

Download Audio
Tuesday, July 28 2015
Produced By
Featured in storyDr Deborah Gleeson - Public Health Lecturer at La Trobe University and Trade Agreement Representative for Public Health Association of AustraliaDr Matthew Rimmer, Professor of Intellectual Property and Innovation Law at the Queensland University of Technology
Category

The Wire is produced in partnership by

Contributor Stations

Supporters and Program Distribution